Most high-risk drug users substituted their preferred drug with another, with synthetic cannabinoids replacing cannabis in 33% of cases

Among 592 high-risk drug users in treatment, 75.7% reported substituting their preferred drug, with 33.5% of cannabis users switching to synthetic cannabinoids and 35.9% of heroin users switching to street methadone.

Shapira, Barak et al.·PeerJ·2020·Moderate EvidenceCross-Sectional
RTHC-02838Cross SectionalModerate Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Moderate Evidence
Sample
N=592

What This Study Found

448 of 592 high-risk drug users (75.7%) reported substituting their preferred drug. Cannabis users most commonly substituted synthetic cannabinoid receptor agonists (33.5%) followed by alcohol (16%). Heroin users most commonly substituted street methadone (35.9%) followed by prescription opioids (17.7%). Age at onset, education, and treatment setting predicted substitution patterns.

Key Numbers

592 users; 75.7% reported substitution; cannabis→synthetic cannabinoids 33.5%; cannabis→alcohol 16%; heroin→street methadone 35.9%; heroin→prescription opioids 17.7%.

How They Did This

Cross-sectional interviews with 592 high-risk drug users in pharmacological and psychosocial treatment, assessing lifetime substitution patterns for heroin and cannabis using descriptive statistics and multinomial logistic regression.

Why This Research Matters

Drug substitution is a clinical reality that treatment programs rarely address. When cannabis is unavailable, users may switch to more dangerous synthetic cannabinoids. Understanding these patterns helps predict risks when supply is disrupted.

The Bigger Picture

The high rate of cannabis-to-synthetic-cannabinoid substitution has direct policy implications: restricting cannabis access without addressing synthetic alternatives may push users toward more dangerous products.

What This Study Doesn't Tell Us

High-risk treatment population (may not represent casual users); Israeli sample (drug availability differs from US/Europe); self-report of substitution; retrospective; cannot determine health outcomes of substitution.

Questions This Raises

  • ?Would cannabis legalization reduce synthetic cannabinoid use?
  • ?Should treatment programs screen for substitution behavior to prevent escalation?

Trust & Context

Key Stat:
75.7% substituted drugs; 33.5% of cannabis users switched to synthetic cannabinoids
Evidence Grade:
Moderate: reasonable sample with clinical population, but cross-sectional and self-report.
Study Age:
Published 2020.
Original Title:
The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users.
Published In:
PeerJ, 8, e9461 (2020)
Database ID:
RTHC-02838

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

What do cannabis users switch to when cannabis is unavailable?

In this high-risk population, 33.5% of cannabis users substituted synthetic cannabinoids (which are more potent and dangerous), followed by alcohol (16%). This suggests restricting cannabis access may inadvertently push users toward riskier substances.

Is drug substitution common?

Very. Over three-quarters (75.7%) of high-risk drug users reported substituting their preferred drug for another substance at some point, driven by cost, availability, safety perceptions, and legal concerns.

Read More on RethinkTHC

Cite This Study

RTHC-02838·https://rethinkthc.com/research/RTHC-02838

APA

Shapira, Barak; Rosca, Paola; Berkovitz, Ronny; Gorjaltsan, Igor; Neumark, Yehuda. (2020). The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users.. PeerJ, 8, e9461. https://doi.org/10.7717/peerj.9461

MLA

Shapira, Barak, et al. "The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users.." PeerJ, 2020. https://doi.org/10.7717/peerj.9461

RethinkTHC

RethinkTHC Research Database. "The switch from one substance-of-abuse to another: illicit d..." RTHC-02838. Retrieved from https://rethinkthc.com/research/shapira-2020-the-switch-from-one

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.